Mutation Analysis in Non-Small Cell Lung Cancer Samples
Author Information
Author(s): van Eijk Ronald, Licht Jappe, Schrumpf Melanie, Talebian Yazdi Mehrdad, Ruano Dina, Forte Giusi I., Nederlof Petra M., Veselic Maud, Rabe Klaus F., Annema Jouke T., Smit Vincent, Morreau Hans, van Wezel Tom
Primary Institution: Leiden University Medical Center
Hypothesis
Can allele-specific qPCR reliably detect mutations in fine needle aspirates from NSCLC patients?
Conclusion
Molecular profiling can be reliably performed on fine needle cytology aspirates from NSCLC patients.
Supporting Evidence
- All mutations detected in the histological material of primary tumors were also identified in the cytological samples.
- The overall call rate in the assays was 95%, indicating high reliability.
- Mutation results from cytological specimens and primary tumors were highly concordant.
Takeaway
Doctors can use a special test to find cancer mutations in tiny samples from lung cancer patients, helping them choose the best treatment.
Methodology
The study used allele-specific quantitative real-time PCR to analyze mutations in fine needle aspirates from NSCLC patients and compared results with histological samples.
Limitations
The study only focused on hotspot mutations and may miss other mutations.
Participant Demographics
43 patients with NSCLC, including 14 squamous cell carcinomas, 15 adenocarcinomas, 3 adenosquamous carcinomas, and 1 large cell carcinoma.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website